Mereo BioPharma (MREO) Depreciation & Amortization (CF) (2023 - 2026)
Mereo BioPharma (MREO) reported Depreciation & Amortization (CF) of $44000.0 for Q1 2026, up 15.79% year-over-year from $38000.0 in Q1 2025, and down 44.3% quarter-over-quarter from $79000.0 in Q4 2025.
Mereo BioPharma (MREO) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 4 years of Depreciation & Amortization (CF) data on file, last reported at $44000.0 in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $44000.0, up 15.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $323000.0 (up 17.03% YoY), and the FY2025 annual result was $200000.0, up 39.86% from the prior year.
- Depreciation & Amortization (CF) declined to $44000.0 in Q1 2026 per MREO's latest filing, from $79000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $100000.0 in Q2 2023 and troughed at $38000.0 in Q4 2024.
- A 4-year average of $71076.9 and a median of $79000.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) decreased 9.52% in 2024, then surged 107.89% in 2025.
- A 4-year view of Depreciation & Amortization (CF) shows it stood at $42000.0 in 2023, then declined by 9.52% to $38000.0 in 2024, then surged by 107.89% to $79000.0 in 2025, then tumbled by 44.3% to $44000.0 in 2026.
- Business Quant data shows MREO's Depreciation & Amortization (CF) at $44000.0 in Q1 2026, $79000.0 in Q4 2025, and $100000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 429,663.65 |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - | 44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44,000.00 |
| Mar 31, 2026 | 44,000.00 |
| Dec 31, 2025 | 79,000.00 |
| Dec 31, 2025 | 79,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 41,000.00 |
| Mar 31, 2024 | 41,000.00 |
| Dec 31, 2023 | 42,000.00 |
| Dec 31, 2023 | 42,000.00 |